You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

CLINICAL TRIALS PROFILE FOR NICORETTE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Nicorette

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00139516 ↗ Chinese Community Smoking Cessation Project Completed National Heart, Lung, and Blood Institute (NHLBI) N/A 2001-09-01 The study has two objectives/aims: Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months
NCT00139516 ↗ Chinese Community Smoking Cessation Project Completed University of California, San Francisco N/A 2001-09-01 The study has two objectives/aims: Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months
NCT00158171 ↗ Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 2002-04-01 Currently one in five high school students smokes. Smoking can harm adolescents well before they reach adulthood by causing a number of immediate, sometimes irreversible, health risks and problems. This study will compare the effectiveness of treatment with bupropion, a nicotine patch, or nicotine gum in supporting the reduction of smoking in adolescent smokers.
NCT00174499 ↗ A Pilot Drug Trial That Evaluates the Whitening Potential of Nicotine Gum Completed McNeil AB Phase 4 2005-07-01 The purpose of this research study is to evaluate the effects on existing tooth stain of nicotine gum. The study will enroll adults who have visible tooth staining.
NCT00176449 ↗ A Comparison of Bupropion SR and Placebo for Smoking Cessation Completed US Department of Veterans Affairs Phase 4 2001-04-01 The purpose of this study is to examine whether the adjunctive use of bupropion SR in the context of a psychoeducational program modified for people with schizophrenia might improve the likelihood of successful abstinence in this population. If bupropion SR is effective for reducing cigarette smoking, then it will be important to determine if decreased nicotine intake is associated with a worsening of psychotic, anxiety or depressive symptoms. In addition, it would be important to determine the effect that a reduction in nicotine stimulation would have on patient's cognitive functioning, as nicotinic receptors have been shown to regulate attention and memory function, and it is hypothesized that these functions are normalized by acute nicotine administration in people with schizophrenia
NCT00176449 ↗ A Comparison of Bupropion SR and Placebo for Smoking Cessation Completed VA Office of Research and Development Phase 4 2001-04-01 The purpose of this study is to examine whether the adjunctive use of bupropion SR in the context of a psychoeducational program modified for people with schizophrenia might improve the likelihood of successful abstinence in this population. If bupropion SR is effective for reducing cigarette smoking, then it will be important to determine if decreased nicotine intake is associated with a worsening of psychotic, anxiety or depressive symptoms. In addition, it would be important to determine the effect that a reduction in nicotine stimulation would have on patient's cognitive functioning, as nicotinic receptors have been shown to regulate attention and memory function, and it is hypothesized that these functions are normalized by acute nicotine administration in people with schizophrenia
NCT00176449 ↗ A Comparison of Bupropion SR and Placebo for Smoking Cessation Completed University of Maryland Phase 4 2001-04-01 The purpose of this study is to examine whether the adjunctive use of bupropion SR in the context of a psychoeducational program modified for people with schizophrenia might improve the likelihood of successful abstinence in this population. If bupropion SR is effective for reducing cigarette smoking, then it will be important to determine if decreased nicotine intake is associated with a worsening of psychotic, anxiety or depressive symptoms. In addition, it would be important to determine the effect that a reduction in nicotine stimulation would have on patient's cognitive functioning, as nicotinic receptors have been shown to regulate attention and memory function, and it is hypothesized that these functions are normalized by acute nicotine administration in people with schizophrenia
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Nicorette

Condition Name

Condition Name for Nicorette
Intervention Trials
Tobacco Dependence 15
Smoking Cessation 11
Tobacco Use Disorder 7
Smoking 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Nicorette
Intervention Trials
Tobacco Use Disorder 22
Cardiovascular Diseases 1
Pulmonary Disease, Chronic Obstructive 1
Lung Diseases, Obstructive 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Nicorette

Trials by Country

Trials by Country for Nicorette
Location Trials
United States 17
Sweden 12
China 4
South Africa 3
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Nicorette
Location Trials
Minnesota 2
Nebraska 2
North Carolina 2
Wisconsin 2
Maryland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Nicorette

Clinical Trial Phase

Clinical Trial Phase for Nicorette
Clinical Trial Phase Trials
Phase 4 7
Phase 2/Phase 3 1
Phase 2 4
[disabled in preview] 29
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Nicorette
Clinical Trial Phase Trials
Completed 37
Recruiting 3
Unknown status 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Nicorette

Sponsor Name

Sponsor Name for Nicorette
Sponsor Trials
McNeil AB 14
National Institute on Drug Abuse (NIDA) 4
VA Office of Research and Development 3
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Nicorette
Sponsor Trials
Industry 29
Other 28
NIH 9
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.